Perspective Therapeutics (CATX) Inventory Average (2011 - 2023)
Perspective Therapeutics recorded quarterly Inventory Average of $1.1 million in Q3 2023, down 15.79% quarter-over-quarter from $1.3 million in Q2 2023, and down 28.55% year-over-year from $1.5 million in Q3 2022.
Perspective Therapeutics' Inventory Average history runs 12 years deep, the most recent figure standing at $1.1 million for Q3 2023.
- In Q3 2023, Inventory Average fell 28.55% year-over-year to $1.1 million; the TTM figure through Sep 2023 stood at $1.1 million (down 28.55% YoY), while the FY2022 annual figure was $1.4 million, changed N/A from the prior year.
- Inventory Average came in at $1.1 million for Q3 2023 at Perspective Therapeutics, down from $1.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $1.5 million in Q4 2022 to a low of $513500.0 in Q1 2019.
- A 5-year average of $908184.2 and a median of $855500.0 in 2021 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average surged 62.94% in 2021 and slipped 28.55% in 2023, its largest moves.
- Perspective Therapeutics' Inventory Average stood at $523000.0 in 2019, then increased by 24.86% to $653000.0 in 2020, then soared by 62.94% to $1.1 million in 2021, then soared by 39.19% to $1.5 million in 2022, then dropped by 28.87% to $1.1 million in 2023.
- According to Business Quant data, Inventory Average over the past three periods registered $1.1 million, $1.3 million, and $1.4 million for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.23 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.49 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 661.35 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 652.65 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 855,500.00 |
| Mar 31, 2021 | 698,000.00 |
| Dec 31, 2020 | 653,000.00 |
| Sep 30, 2020 | 643,000.00 |
| Jun 30, 2020 | 612,500.00 |
| Mar 31, 2020 | 562,500.00 |
| Dec 31, 2019 | 523,000.00 |
| Sep 30, 2019 | 515,500.00 |
| Jun 30, 2019 | 531,500.00 |
| Mar 31, 2019 | 513,500.00 |
| Dec 31, 2018 | 490,500.00 |
| Sep 30, 2018 | 490,500.00 |
| Jun 30, 2018 | 476,000.00 |
| Mar 31, 2018 | 458,500.00 |
| Dec 31, 2017 | 456,000.00 |
| Sep 30, 2017 | 388,000.00 |
| Jun 30, 2017 | 318,500.00 |
| Mar 31, 2017 | 347,500.00 |
| Dec 31, 2016 | 380,500.00 |
| Sep 30, 2016 | 357,000.00 |
| Jun 30, 2016 | 395,645.50 |
| Mar 31, 2016 | 467,020.00 |
| Jun 30, 2014 | 373,378.50 |
| Mar 31, 2014 | 406,676.50 |
| Dec 31, 2013 | 431,288.50 |
| Sep 30, 2013 | 420,907.50 |
| Jun 30, 2013 | 381,274.00 |
| Mar 31, 2013 | 379,944.50 |
| Dec 31, 2012 | 406,688.00 |
| Sep 30, 2012 | 427,404.50 |
| Jun 30, 2012 | 442,769.50 |
| Mar 31, 2012 | 623,689.00 |
| Dec 31, 2011 | 784,045.00 |
| Sep 30, 2011 | 755,877.50 |